Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News electroCore, Inc. ECOR

Healthcare Medical Devices
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS... see more

Recent & Breaking News (NDAQ:ECOR)

electroCore Announces Two-Year Extension of gammaCore(TM) Device Listing in the NHS Supply Chain Catalogue

GlobeNewswire October 17, 2023

electroCore Expands Intellectual Property Portfolio for Non-Invasive Vagus Nerve Stimulation (nVNS) Technology

GlobeNewswire October 11, 2023

Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Neurological Injury Presented at 2023 World Stroke Congress

GlobeNewswire October 10, 2023

electroCore to Announce Third Quarter Financial Results on Wednesday, November 8

GlobeNewswire October 9, 2023

electroCore to Participate in the Lytham Partners Fall 2023 Virtual Investor Conference

GlobeNewswire October 5, 2023

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improves Attention and Working Memory in Patients with Post Traumatic Stress Disorder (PTSD)

GlobeNewswire September 27, 2023

electroCore Expands Intellectual Property Portfolio for Non-Invasive Vagus Nerve Stimulation (nVNS) Technology

GlobeNewswire September 26, 2023

iAccess Alpha Best Ideas from the Buyside Virtual Conference - Sep 26th-27th 2023

Accesswire September 25, 2023

electroCore to Participate in the LD Micro Main Event XVI Conference

GlobeNewswire September 25, 2023

electroCore to Present at iAccess Alpha's - Top 10 Best Ideas from the Buyside Virtual Conference

GlobeNewswire September 21, 2023

electroCore to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

GlobeNewswire September 7, 2023

electroCore Announces Dismissal of All Litigation Related to Its 2018 Initial Public Offering

GlobeNewswire August 23, 2023

electroCore Announces Second Quarter 2023 Financial Results

GlobeNewswire August 9, 2023

electroCore to Announce Second Quarter Financial Results on Wednesday, August 9

GlobeNewswire August 1, 2023

electroCore, Inc. Announces $8.145 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules

GlobeNewswire July 31, 2023

gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Improves Attention and Memory in Patients with Posttraumatic Stress Disorder (PTSD)

GlobeNewswire July 25, 2023

electroCore Expands Intellectual Patent Portfolio for nVNS Technology

GlobeNewswire July 18, 2023

electroCore, Inc. Announces Distribution Agreement with Reliefband Technologies, LLC

GlobeNewswire July 13, 2023

electroCore Provides Select Second Quarter 2023 Financial Guidance

GlobeNewswire July 11, 2023

gammaCore(TM) Non-Invasive Vagal Nerve Stimulation Selected for Study Funded by the National Football League (NFL) and National Football League Players Association (NFLPA) on Alleviating Concussion Symptoms

GlobeNewswire July 6, 2023